Literature DB >> 16783862

PPAR-gamma gene polymorphisms and psoriatic arthritis.

Christopher Butt1, Dafna Gladman, Proton Rahman.   

Abstract

OBJECTIVE: Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation has been shown to play a role in suppressing angiogenesis and inflammation, both important pathological features of psoriatic arthritis (PsA). Given the potential physiological role for PPAR-gamma in PsA, we examined known coding polymorphisms in the PPAR-gamma gene in a Caucasian population.
METHODS: PsA was diagnosed as an inflammatory arthritis in patients with psoriasis, in the absence of other etiologies for inflammatory arthritis. Control subjects were ascertained from the same population and were all Caucasian. DNA samples were genotyped for 4 PPAR-gamma variants by time-of-flight mass spectrometry using the Sequenom platform. All 4 single-nucleotide polymorphisms (SNP) were previously-reported coding variations, 3 of which caused an amino acid change: Pro12Ala (rs1801282), Pro40Ala (rs1805192), and Pro115Gln (rs1800571); the fourth SNP, C161T (rs3856806), was synonymous. All primers were designed using Sequenom SpectroDesigner software, and scanned using a mass spectrometry workstation.
RESULTS: Of the 4 SNP examined, Pro40Ala and Pro115Gln were found to be nonpolymorphic in our population. Minor allele frequency for patients with PsA and controls for Pro12Ala (G) were 9.0% vs 13.8% (p = 0.017) and for C161T (T) 10.7% vs 12.0% (p = 0.56), respectively. All genotypes satisfied Hardy-Weinberg equilibrium.
CONCLUSION: An association between PsA and a known coding SNP of the PPAR-gamma gene was observed in our Caucasian population. Further studies are now warranted for validation of our findings in an independent cohort.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783862

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Genet Test Mol Biomarkers       Date:  2014-04-03

2.  VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis.

Authors:  Christopher Butt; Sooyeol Lim; Celia Greenwood; Proton Rahman
Journal:  BMC Musculoskelet Disord       Date:  2007-01-04       Impact factor: 2.362

3.  A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility.

Authors:  Elena López-Isac; Lara Bossini-Castillo; Carmen P Simeon; María Victoria Egurbide; Juan José Alegre-Sancho; Jose Luis Callejas; José Andrés Roman-Ivorra; Mayka Freire; Lorenzo Beretta; Alessandro Santaniello; Paolo Airó; Claudio Lunardi; Nicolas Hunzelmann; Gabriela Riemekasten; Torsten Witte; Alexander Kreuter; Jörg H W Distler; Annemie J Schuerwegh; Madelon C Vonk; Alexandre E Voskuyl; Paul G Shiels; Jacob M van Laar; Carmen Fonseca; Christopher Denton; Ariane Herrick; Jane Worthington; Shervin Assassi; Bobby P Koeleman; Maureen D Mayes; Timothy R D J Radstake; Javier Martin
Journal:  Arthritis Res Ther       Date:  2014-01-09       Impact factor: 5.156

4.  Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms.

Authors:  C Rodríguez-Cerdeira; A Molares-Vila; E Sánchez-Blanco; B Sánchez-Blanco
Journal:  Open Biochem J       Date:  2014-02-21

5.  The Pro12Ala Polymorphism of PPAR-γ Gene Is Associated with Sepsis Disease Severity and Outcome in Chinese Han Population.

Authors:  Guoda Ma; Haiyang Wang; Guixi Mo; Lili Cui; You Li; Yiming Shao; Xin Liu; Yuliu Xie; Jia Li; Jiawu Fu; Hua Tao; Bin Zhao; Liangqing Zhang; Keshen Li
Journal:  PPAR Res       Date:  2014-07-20       Impact factor: 4.964

6.  The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus.

Authors:  Leila Saremi; Shirin Lotfipanah; Masumeh Mohammadi; Hassan Hosseinzadeh; Mina Fathi-Kazerooni; Behrooz Johari; Zohreh Saltanatpour
Journal:  Cell Mol Biol Lett       Date:  2019-03-15       Impact factor: 5.787

7.  Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of disease.

Authors:  Suyan Tian; James G Krueger; Katherine Li; Ali Jabbari; Carrie Brodmerkel; Michelle A Lowes; Mayte Suárez-Fariñas
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

8.  Quantitative PPARγ expression affects the balance between tolerance and immunity.

Authors:  Ya-Hui Liu; Yau-Sheng Tsai; Shih-Chieh Lin; Nan-Shih Liao; Ming-Shiou Jan; Chung-Tiang Liang; Shih-Wen Hsu; Wen-Chung Chen; Junne-Ming Sung; Nobuyo Maeda; Pei-Jane Tsai
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

9.  Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis.

Authors:  Nikolai Dyrberg Loft; Lone Skov; Mads Kirchheiner Rasmussen; Robert Gniadecki; Tomas Norman Dam; Ivan Brandslund; Hans Jürgen Hoffmann; Malene Rohr Andersen; Ram Benny Dessau; Ann Christina Bergmann; Niels Møller Andersen; Mikkel Kramme Abildtoft; Paal Skytt Andersen; Merete Lund Hetland; Bente Glintborg; Steffen Bank; Ulla Vogel; Vibeke Andersen
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.